Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-21 4:30 pm Sale | 2025-02-19 | 13D | Royalty Pharma plc RPRX | Severgnini Achille G. | 36,001,535 8.300% | -5,649,635 (-13.56%) | Filing History |
| 2025-02-12 09:30 am Sale | 2024-12-31 | 13G | Royalty Pharma plc RPRX | FMR CORP | 26,309,327 5.900% | -5,274,599 (-16.70%) | Filing History |
| 2025-02-04 3:45 pm Purchase | 2024-12-31 | 13G | Royalty Pharma plc RPRX | BlackRock Inc. BLK | 25,445,414 5.700% | 25,445,414 (New Position) | Filing History |
| 2024-11-08 3:15 pm Sale | 2024-09-30 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 36,517,159 8.200% | -4,642,590 (-11.28%) | Filing History |
| 2024-07-29 4:30 pm Purchase | 2024-07-09 | 13D | Royalty Pharma plc RPRX | Severgnini Achille G. | 41,651,170 13.000% | 41,651,170 (New Position) | Filing History |
| 2024-02-13 5:13 pm Purchase | 2023-12-29 | 13G | Royalty Pharma plc RPRX | VANGUARD GROUP INC | 37,997,522 8.540% | 2,369,731 (+6.65%) | Filing History |
| 2024-02-13 10:17 am Purchase | 2023-12-31 | 13G | Royalty Pharma plc RPRX | GENERAL ATLANTIC LLC | 26,259,141 5.600% | 14,400 (+0.05%) | Filing History |
| 2024-02-09 3:13 pm Sale | 2023-12-31 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 41,159,749 9.200% | -2,615,649 (-5.98%) | Filing History |
| 2024-02-09 09:49 am Sale | 2024-02-08 | 13G | Royalty Pharma plc RPRX | FMR CORP | 31,583,926 7.099% | -12,526,439 (-28.40%) | Filing History |
| 2023-02-13 4:53 pm Purchase | 2022-12-31 | 13G | Royalty Pharma plc RPRX | GENERAL ATLANTIC LLC | 26,244,741 5.600% | 871 (+0.00%) | Filing History |
| 2023-02-10 3:21 pm Sale | 2022-12-30 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 43,775,398 9.900% | -12,235,612 (-21.85%) | Filing History |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | Royalty Pharma plc RPRX | FMR CORP | 44,110,365 9.999% | 22,030,570 (+99.78%) | Filing History |
| 2023-02-09 11:32 am Purchase | 2022-12-30 | 13G | Royalty Pharma plc RPRX | VANGUARD GROUP INC | 35,627,791 8.080% | 5,991,226 (+20.22%) | Filing History |
| 2023-02-09 11:06 am Sale | 2022-12-31 | 13G | Royalty Pharma plc RPRX | ADAGE CAPITAL PARTNERS GP LLC | 7,000,000 1.590% | -17,842,715 (-71.82%) | Filing History |
| 2022-10-04 4:30 pm Sale | 2022-10-04 | 13D | Royalty Pharma plc RPRX | Giuliani Mario Germano | 43,816,170 10.000% | -2,500,000 (-5.40%) | Filing History |
| 2022-08-11 08:30 am Unchanged | 2022-08-09 | 13D | Royalty Pharma plc RPRX | Giuliani Mario Germano | 46,316,170 10.600% | 0 (Unchanged) | Filing History |
| 2022-04-05 4:01 pm Unchanged | 2022-04-01 | 13D | Royalty Pharma plc RPRX | Giuliani Mario Germano | 46,316,170 10.700% | 0 (Unchanged) | Filing History |
| 2022-02-10 4:43 pm Purchase | 2021-12-31 | 13G | Royalty Pharma plc RPRX | MORGAN STANLEY MS | 56,011,010 13.000% | 9,866,127 (+21.38%) | Filing History |
| 2022-02-10 10:44 am Sale | 2021-12-31 | 13G | Royalty Pharma plc RPRX | ADAGE CAPITAL PARTNERS GP LLC | 24,842,715 5.780% | -13,871,565 (-35.83%) | Filing History |
| 2022-02-10 08:37 am Purchase | 2021-12-31 | 13G | Royalty Pharma plc RPRX | VANGUARD GROUP INC | 29,636,565 6.900% | 29,636,565 (New Position) | Filing History |